Biology and outcome registry for acute leukemia patients
Part of Blood & lymphatic, Cancer clinical trials.
This is a research registry that collects information and lab/blood sample data to better understand what acute leukemia looks like biologically and how patients do over time. It may help future treatment decisions, but it does not describe testing a new drug.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older
- You have suspected, newly diagnosed, or relapsed/“not responding” acute leukemia (and related conditions)
- You must be able to understand the study and agree to it in writing
- You must agree to have your clinical and disease information recorded and used for research
- You must agree to store your blood/tissue samples (biobanking) and to analyze them later
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study enrolls adults with acute myeloid leukemia (AML) to build a detailed registry and store biological samples. It helps researchers understand AML better and may support future studies.
This non-interventional study follows adults with acute myeloid leukemia (AML) to better understand the disease and how patients do in real-world care. It may help researchers compare outcomes across different types of AML, but you would not receive a study treatment just for joining.
This study collects information from people with myelodysplastic syndrome (MDS) or acute myeloid leukemia (AML) that developed after cancer treatment. It does not test a new drug but helps doctors learn more about these conditions.
This registry collects information from adults with AML diagnosed since 2020. It helps doctors understand and improve treatment for this blood cancer.
This is a registry (a study that collects health information over time) for adults with suspected or confirmed blood cancers of the myeloid type. It aims to better understand the biology of these illnesses and how different factors affect outcomes, which may improve care in the future.
This study collects samples and health information from people with certain blood cancers to learn more about the disease and find markers that may help guide future treatments. You will not receive a treatment from this study, but you may help advance research.
Hear when a new Acute Myeloid Leukemia (AML) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.